William Wilcox, MD, PhD is currently a clinical, biochemical and molecular geneticist in the division of medical genetics at Emory University, School of Medicine. He specializes in the diagnosis and treatment of metabolic disorders and genetic disorders of the skeleton, particularly dwarfisms and limb deficiency disorders. He is board certified by the American Board of Medical Genetics in clinical genetics, clinical biochemical genetics, and clinical molecular genetics.
Dr. Wilcox received his Bachelor of Science degree from the University of California, Los Angeles (UCLA) in biochemistry and mathematics. He went on to receive an M.D. from UCLA in 1988 as well as a Ph.D. in molecular biology from UCLA in 1989. In his last year of medical school, Dr. Wilcox was the recipient of the John M. Adams award for excellence in Pediatrics. He went on to do an internship and residency in pediatrics and then completed a medical genetics residency at the UCLA Intercampus Medical Genetics Training Program from 1991- 1994.
For his current research he focuses on clinical trials of therapies for genetic disorders, particularly lysosomal storage disorders. He also researches the genetic basis and pathology of genetic disorders of the skeleton, particularly skeletal dysplasias and limb deficiency disorders. Dr. Wilcox has served as an advisor on the advisory board for the California State Newborn Screening Program and has helped the decision making process to decide which diseases should be screened for in California.
Recently, Emory University, amongst other institutions, was awarded with the Newborn Screening Pompe Pilot Study from the National Institutes of Health. Dr. Wilcox, along with researchers from other institutions, will work to support the development, implementation and proof of concept in newborn screening for Pompe disease.
The NBSTRN is glad to congratulate Dr. Wilcox as the Newborn Screening Spotlight Researcher of the month and wishes him luck with his future research!